All Stories

  1. Meta-analysis of clinical and safety profiles after reperfusion therapy in acute posterior circulation strokes: insights and implications
  2. Pupillometer-Based Neurological Pupil Index Differential: A Potential Predictor of Post-Stroke Delirium
  3. Introducing the Futile Recanalization Prediction Score (FRPS): A Novel Approach to Predict and Mitigate Ineffective Recanalization after Endovascular Treatment of Acute Ischemic Stroke
  4. Digital biomarkers: 3PM approach revolutionizing chronic disease management — EPMA 2024 position
  5. Burden of disease scenarios for 204 countries
  6. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  7. Advancing Understanding and Addressing Disparities in Cardiomyopathy Care in Southern Africa
  8. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  9. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  10. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
  11. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  12. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  13. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  14. Chronic kidney disease prevalence and clinical outcomes in anterior circulation acute ischemic stroke patients with reperfusion therapy: A meta‐analysis
  15. Diagnosis and Management of Atrial Fibrillation in Acute Ischemic Stroke in the Setting of Reperfusion Therapy: Insights and Strategies for Optimized Care
  16. Prevalence and Impact of Cerebral Microbleeds on Clinical and Safety Outcomes in Acute Ischaemic Stroke Patients Receiving Reperfusion Therapy: A Systematic Review and Meta-Analysis
  17. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  18. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  19. Comprehensive Meta-Analysis of Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: Prevalence, Factors, and Clinical Outcomes
  20. Atrial Fibrillation and Reperfusion Therapy in Acute Ischaemic Stroke Patients: Prevalence and Outcomes—A Comprehensive Systematic Review and Meta-Analysis
  21. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  22. Australia's Health Evolution: 1990-2019 Disease and Risk Factor Trends
  23. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  24. Bridging the Gap in Cancer-Related Stroke Management: Update on Therapeutic and Preventive Approaches
  25. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
  26. An Equity and Justice-Informed Ethical Framework to Guide Incidental Findings in Brain Imaging Research
  27. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
  28. When Two Maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer
  29. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis
  30. Association of Lesion Topography with Functional Outcomes in Acute Ischemic Stroke Patients Considered for, or Receiving, Reperfusion Therapy: A Meta-Analysis
  31. Editorial: Telemedicine during and beyond COVID-19, volume II
  32. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  33. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
  34. Clot Morphology in Acute Ischemic Stroke Decision Making
  35. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  36. COVID-19 and the cardiovascular system-current knowledge and future perspectives
  37. Is Composition of Brain Clot Retrieved by Mechanical Thrombectomy Associated with Stroke Aetiology and Clinical Outcomes in Acute Ischemic Stroke?—A Systematic Review and Meta-Analysis
  38. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  39. Incidental findings in brain imaging research: spotlight on ethical considerations
  40. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  41. Telemedicine during and post-COVID 19: The insights of neurosurgery patients and physicians
  42. Optic nerve infiltration by large B-cell lymphoma
  43. Successful mechanical thrombectomy of the left superior cerebellar artery
  44. The association of transradial access and transfemoral access with procedural outcomes in acute ischemic stroke patients receiving endovascular thrombectomy: A meta-analysis
  45. Prognostic accuracy and impact of cerebral collateral status on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: a systematic meta-analysis
  46. Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
  47. Impact of diabetes on clinical and safety outcomes in acute ischemic stroke patients receiving reperfusion therapy: A meta-analysis
  48. Incidence of white matter lesions in hospitalised COVID‐19 patients: a meta‐analysis
  49. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  50. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
  51. Clinical outcomes following reperfusion therapy in acute ischemic stroke patients with infective endocarditis: a systematic review
  52. Role of Neutrophil-Lymphocyte Ratio in the Prognosis of Acute Ischaemic Stroke After Reperfusion Therapy: A Systematic Review and Meta-analysis
  53. Prognostic Role of the Platelet-Lymphocyte Ratio in Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy: A Meta-Analysis
  54. Cardiovascular Complications of COVID-19
  55. Diagnostic and prognostic utility of brain collaterals in acute ischaemic stroke: Current knowledge and insights on treatment decision-making
  56. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
  57. Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
  58. Prevalence of paediatric hyperinflammatory conditions in paediatric and adolescent hospitalised COVID‐19 patients: a systematic review and meta‐analysis
  59. A Multicentre Study Comparing Cerebrovascular Disease Profiles in Pacific Islander and Caucasian Populations Presenting with Stroke and Transient Ischaemic Attack
  60. Brain atrophy in acute ischaemic stroke patients treated with reperfusion therapy: a systematic review
  61. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  62. Stroke Aetiology and Collateral Status in Acute Ischemic Stroke Patients Receiving Reperfusion Therapy—A Meta-Analysis
  63. Creutzfeldt-Jakob Disease in South West Sydney 2014–2020: An Unusually High Incidence of a Rare Disease
  64. Value of pre-intervention CT perfusion imaging in acute ischemic stroke prognosis
  65. Stroke in Patients with Diabetes: Is It Time to Expand Public Health Priority to Encompass High-Risk Patients with Increased Insulin Resistance?
  66. Optimising Prehospital Pathways to Improve Acute Stroke Reperfusion Therapy Delivery: Systems-Based Approaches
  67. In‐hospital prevalence of mucormycosis among coronavirus disease 2019 (COVID‐19) patients and COVID‐19 in mucormycosis: a systematic review and meta‐analysis
  68. Acute Ischaemic Stroke in Infective Endocarditis: Pathophysiology and Clinical Outcomes in Patients Treated with Reperfusion Therapy
  69. Hypertensive urgencies during the first wave of COVID-19 pandemic in a tertiary hospital setting: A “U” shaped alarming curve.
  70. Digital subtraction angiography in cerebrovascular disease: current practice and perspectives on diagnosis, acute treatment and prognosis
  71. Role of Diabetes in Stroke: Recent Advances in Pathophysiology and Clinical Management
  72. Tracking development assistance for health and for COVID-19
  73. Leukoaraiosis severity and post‐reperfusion outcomes in acute ischaemic stroke: A meta‐analysis
  74. Value of pre-intervention computed tomography perfusion imaging in the assessment of tissue outcome and long-term clinical prognosis in patients with anterior circulation acute ischemic stroke receiving reperfusion therapy: a systematic review
  75. Measuring routine childhood vaccination coverage in 204 countries and territories
  76. Emerging role of white matter lesions in cerebrovascular disease
  77. Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis
  78. In‐hospital systems interventions in acute stroke reperfusion therapy: a meta‐analysis
  79. Hyperdense MCA (HDMCA) sign in acute ischemic stroke patients receiving reperfusion therapy
  80. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
  81. Diagnostic and Prognostic Utility of CT Perfusion Imaging in Posterior Circulation Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
  82. Is COVID-19 Another Case of Obesity Paradox? - Results from An International Ecological Study on behalf of the REPROGRAM Consortium Obesity
  83. Practical Design of Flow Meter for Mechanical Ventilation Equipment
  84. Effect of prehospital workflow optimization on treatment delays and clinical outcomes in acute ischemic stroke: A systematic review and meta‐analysis
  85. Editorial: Telemedicine During and Beyond COVID-19
  86. Telemedicine During and Beyond COVID-19
  87. Call for Action to Address Equity and Justice Divide During COVID-19
  88. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
  89. CTP‐guided reperfusion therapy in acute ischemic stroke: a meta‐analysis
  90. Addressing the Covid-19 Burden on Medical Education and Training: The Role of Telemedicine and Tele-Education During and Beyond the Pandemic
  91. At the Epicenter of COVID-19–the Tragic Failure of the Global Supply Chain for Medical Supplies
  92. Designing Futuristic Telemedicine Using Artificial Intelligence and Robotics in the COVID-19 Era
  93. Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) International Consortium (Part 1)
  94. In‐hospital acute stroke workflow in acute stroke – Systems‐based approaches
  95. Cerebral collaterals in acute ischaemia: Implications for acute ischaemic stroke patients receiving reperfusion therapy
  96. Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2)
  97. Separating posterior-circulation stroke from vestibular neuritis with quantitative vestibular testing
  98. Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
  99. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium
  100. Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium
  101. Acute Neurological Care in the COVID-19 Era: The Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium Pathway
  102. Comparison of ABC Methods with Computerized Estimates of Intracerebral Hemorrhage Volume: The INTERACT2 Study
  103. Hemiprosopometamorphopsia: a Case of Impaired Facial Perception Restricted to the Eye
  104. Impact of obesity-induced type 2 diabetes on long-term outcomes following stroke
  105. Trends in acute stroke presentations to an emergency department: implications for specific communities in accessing acute stroke care services
  106. Clot Histopathology in Ischemic Stroke with Infective Endocarditis
  107. Reperfusion therapy in acute ischemic stroke: dawn of a new era?
  108. Factors Associated with Stroke Misdiagnosis in the Emergency Department: A Retrospective Case-Control Study
  109. Clarion call for histopathological clot analysis in “cryptogenic” ischemic stroke: implications for diagnosis and treatment
  110. The influence of initial stroke severity on mortality, overall functional outcome and in-hospital placement at 90 days following acute ischemic stroke: A tertiary hospital stroke register study
  111. Association of Cortical Vein Filling with Clot Location and Clinical Outcomes in Acute Ischaemic Stroke Patients
  112. Baseline collateral status and infarct topography in post-ischaemic perilesional hyperperfusion: An arterial spin labelling study
  113. Delay of late-venous phase cortical vein filling in acute ischemic stroke patients: Associations with collateral status
  114. Recent progress in migraine pathophysiology: role of cortical spreading depression and magnetic resonance imaging
  115. Cancer stem cells in solid tumors
  116. Towards an Intelligent Wheelchair System for Users With Cerebral Palsy
  117. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging